期刊文献+

国产雷帕霉素药物洗脱支架Firebird在冠心病复杂病变的临床应用 被引量:1

暂未订购
导出
摘要 目的:评价国产雷帕霉素药物洗脱支架在复杂病变中的安全性及疗效。方法:选择2004年9月-2005年10月间收治的61例冠心病复杂病变患者。61例患者共发现复杂病变82处,82处复杂病变共置入108枚Firebird支架。结果:支架置入成功率100%。住院期间。1例死亡,其余病人手术过程及住院期间无不良心脏事件发生。随访6~18个月,死亡1例,发生急性心肌梗死1例。结论:国产雷帕霉素药物洗脱支架Firebird在冠心病复杂病变治疗中是安全有效的。对复杂病变的疗效明显优于普通裸支架。
出处 《内蒙古医学杂志》 2007年第1期83-84,共2页 Inner Mongolia Medical Journal
  • 相关文献

参考文献3

二级参考文献18

  • 1陈纪林,高润霖,杨跃进,乔树宾,秦学文,姚民,刘海波,吴永健,袁晋青,陈珏,徐波.雷帕霉素药物洗脱支架在冠心病复杂病变中应用的近远期疗效[J].中华心血管病杂志,2004,32(10):867-869. 被引量:28
  • 2Allm jM, Brett SL, Jonathan BG, et al. Stent thrombosis after successful sirolimus-eluting strut implantation. Circulation, 2004,109:1930-1932.
  • 3Pedro A, Lee CH, Francesco S, et al. Early outcome after sirolimus eluting stem implantation in patients with acute coronary syndromes. J Am Coll Cardiol, 2003,41:2093-2099.
  • 4Braunwald E. Unstable angina: A classification. Circulation, 1989,80:410.
  • 5Gallo R, Padu A, Chesebro JH, et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by rapamycin. Ciretdafion, 1998,99:2164-2170.
  • 6Stevea O, Andrew R. The development of rapamycin and its application to steat restenosis. Circulation, 2001,104 : 852-855.
  • 7Morice MC, Sermys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. The REVEL trial. N Engl J Med, 2002,346:1773-1780.
  • 8Patrick W, Muzaffer D, Kengo T, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL trial.Circulation, 2002,106:798-803.
  • 9Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-duting stent. Circulation, 2001,104:2007-2011.
  • 10Sousa JE, Sermys PW, Costa MA. New frontiers in cardiology: drugeluting steat, part Ⅰ. Circulation, 2003,107:2274-.2279.

共引文献45

同被引文献15

  • 1陈纪林,高润霖,杨跃进,乔树宾,秦学文,姚民,刘海波,吴永健,袁晋青,陈珏,徐波.雷帕霉素药物洗脱支架在冠心病复杂病变中应用的近远期疗效[J].中华心血管病杂志,2004,32(10):867-869. 被引量:28
  • 2朱国英.药物涂层支架的应用[J].心肺血管病杂志,2005,24(1):51-53. 被引量:12
  • 3王羽,赵明钢,霍勇,等.卫生部心血管疾病介入诊疗技术培训教材冠心病分册[M].北京:卫生部医政司,2009:154.
  • 4Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a sirolimus eluting sent with a standard stent for coronary revascularization[J].N Engl J Med,2002,246(23):1773-1780.
  • 5Moes JW,Leon MB,Popma JJ,et al.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery[J].N Engl J Med,2003,349(7):1315-1323.
  • 6Park SJ,Kim YH,Lee BK,et al.Sirolimous-eluting stent implantation for unprotected left main coronary atery senosis comparison with bare metal stent implantaion[J].J Am Coll Cardiol,2005,45(3):351-356.
  • 7Silber S,Albertsson P,Aviles FF,et al.Guidelines for percutaneous coronary interventions.The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology[J].Eur Heart J,2005,26(8):804-847.
  • 8Cutlip DE,Windecker S,Mehran R,et al.Clinical end points in coronary stent trials:a case for standardized definitions[J].Circulation,2007,115:2344-2351.
  • 9Stone GW,Moses JW,Ellis SG,et al.Safety and efficacy of sirolimus-and paclitaxel-luting coronary stents[J].N Engl J Med,2007,356:998-1008.
  • 10Finn AV,Palacios IF,Kastrati A,et al.Drug-eluting stents for diabetes mellitus:a rush to judgment[J].J Am Coll Cardiol,2005,45(4):479-483.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部